Advanced search
Publication Cover
Drug Delivery Volume 25, 2018 - Issue 1
Submit an article Journal homepage
2,909
Views
61
CrossRef citations to date
0
Altmetric
Research Article

Dual-modified cationic liposomes loaded with paclitaxel and survivin siRNA for targeted imaging and therapy of cancer stem cells in brain glioma

Xiyang SunDepartment of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China; View further author information
,
Ying ChenDepartment of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China; View further author information
,
Hui ZhaoDepartment of Geriatrics, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China; View further author information
,
Guanglei QiaoDepartment of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China; View further author information
,
Meiyang LiuInstitute of Nano Biomedicine and Engineering, Shanghai Engineering Research Center for Intelligent Instrument for Diagnosis and Therapy, Department of Instrument Science and Engineering, Shanghai Jiao Tong University, Shanghai, PR China; View further author information
,
Chunlei ZhangInstitute of Nano Biomedicine and Engineering, Shanghai Engineering Research Center for Intelligent Instrument for Diagnosis and Therapy, Department of Instrument Science and Engineering, Shanghai Jiao Tong University, Shanghai, PR China; View further author information
,
Daxiang CuiInstitute of Nano Biomedicine and Engineering, Shanghai Engineering Research Center for Intelligent Instrument for Diagnosis and Therapy, Department of Instrument Science and Engineering, Shanghai Jiao Tong University, Shanghai, PR China; ;National Center for Translational Medicine, Collaborative Innovational Center for System Biology, Shanghai Jiao Tong University, Shanghai, PR ChinaView further author information
&
Lijun MaDepartment of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-3042-7588View further author information
ORCID Icon show all
Pages 1718-1727 | Received 27 May 2018, Accepted 25 Jun 2018, Published online: 01 Oct 2018

Citations (61)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Yi Zhao, Ping Yue, Yao Peng, Yuanyuan Sun, Xing Chen, Ze Zhao & Bingjie Han. (2023) Recent advances in drug delivery systems for targeting brain tumors. Drug Delivery 30:1, pages 1-18.
Read now
Hanieh Abbasi, Nadereh Rahbar, Maryam Kouchak, Parna Khalil Dezfuli & Somayeh Handali. (2022) Functionalized liposomes as drug nanocarriers for active targeted cancer therapy: a systematic review. Journal of Liposome Research 32:2, pages 195-210.
Read now
Nagat El Demerdash, Jayanidhi Kedda, Nivi Ram, Henry Brem & Betty Tyler. (2020) Novel therapeutics for brain tumors: current practice and future prospects. Expert Opinion on Drug Delivery 17:1, pages 9-21.
Read now
Yu Xia, Jiayu Zhong, Mingqi Zhao, Ying Tang, Ning Han, Liang Hua, Tiantian Xu, Changbing Wang & Bing Zhu. (2019) Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma. Drug Delivery 26:1, pages 1-11.
Read now

Articles from other publishers (57)

Loredana G. Marcu, Mikaela Dell’Oro & Eva Bezak. (2023) Opportunities in Cancer Therapies: Deciphering the Role of Cancer Stem Cells in Tumour Repopulation. International Journal of Molecular Sciences 24:24, pages 17258.
Crossref
Jianyong Zou. (2023) Site-specific delivery of cisplatin and paclitaxel mediated by liposomes: A promising approach in cancer chemotherapy. Environmental Research 238, pages 117111.
Crossref
Mohsen Safaei, Fatemeh Khalighi, Fatemeh Akhavan Behabadi, Zahra Abpeikar, Arash Goodarzi, Seyed Amin Kouhpayeh, Sohrab Najafipour & Vahid Ramezani. (2023) Liposomal nanocarriers containing siRNA as small molecule-based drugs to overcome cancer drug resistance. Nanomedicine.
Crossref
Izzati Haizan, Dong Hyeok Park, Min Yu Choi, Hyerim Lee & Jin-Ha Choi. (2023) Nanomaterials-Based Exosomes for the Diagnostics and Drug Deliveries of Central Nervous System Diseases. BioChip Journal 17:3, pages 293-307.
Crossref
Nagavendra Kommineni, Ruchita Chaudhari, João Conde, Sedef Tamburaci, Berivan Cecen, Pranjal Chandra & Rajendra Prasad. (2023) Engineered Liposomes in Interventional Theranostics of Solid Tumors. ACS Biomaterials Science & Engineering 9:8, pages 4527-4557.
Crossref
Dong-Dong Wu, Yasmine Ahmed Salah, Ebenezeri Erasto Ngowi, Yan-Xia Zhang, Saadullah Khattak, Nazeer Hussain Khan, Yan Wang, Tao Li, Zi-Hua Guo, Yan-Mei Wang & Xin-Ying Ji. (2023) Nanotechnology prospects in brain therapeutics concerning gene-targeting and nose-to-brain administration. iScience 26:8, pages 107321.
Crossref
Fangrong Zhang, Qin Yang, Sishi Tang, Siyi Jiang, Qiangqiang Zhao, Jian Li, Cong Xu, Jing Liu & Yunfeng Fu. (2023) CD38-targeted and erythrocyte membrane camouflaged nanodrug delivery system for photothermal and chemotherapy in multiple myeloma. International Journal of Pharmaceutics 643, pages 123241.
Crossref
Paniz Siminzar, Mohammad Reza Tohidkia, Elisabeth Eppard, Nasim Vahidfar, Ali Tarighatnia & Ayuob Aghanejad. (2022) Recent Trends in Diagnostic Biomarkers of Tumor Microenvironment. Molecular Imaging and Biology 25:3, pages 464-482.
Crossref
Dongyan Wei, Ni Zhang, Shuang Qu, Hao Wang & Jin Li. (2023) Advances in nanotechnology for the treatment of GBM. Frontiers in Neuroscience 17.
Crossref
Chandrasekharan Rajalekshmi Dhanya, Aarcha Shanmugha Mary & Maya Madhavan. (2022) Aptamer‐siRNA chimeras: Promising tools for targeting HER2 signaling in cancer . Chemical Biology & Drug Design 101:5, pages 1162-1180.
Crossref
Shiming He, Yue Du, Hongyu Tao & Huaiyu Duan. (2023) Advances in aptamer-mediated targeted delivery system for cancer treatment. International Journal of Biological Macromolecules 238, pages 124173.
Crossref
Vilma Petrikaite, Nicola D'Avanzo, Christian Celia & Massimo Fresta. (2023) Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models. Drug Resistance Updates 68, pages 100956.
Crossref
Biao Liu, Jiahao Liu, Xing Hu, Wei Xiang, Weibin Hou, Chao Li, Jinrong Wang, Kun Yao, Jin Tang, Zhi Long, Long Wang & Jianye Liu. (2023) Recent advances in aptamer-based therapeutic strategies for targeting cancer stem cells. Materials Today Bio 19, pages 100605.
Crossref
Sofia Shtykalova, Dmitriy Deviatkin, Svetlana Freund, Anna Egorova & Anton Kiselev. (2023) Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications. Life 13:4, pages 903.
Crossref
Arjun Sabu, Te-I Liu, Siew Suan Ng, Ruey-An Doong, Yu-Fen Huang & Hsin-Cheng Chiu. (2022) Nanomedicines Targeting Glioma Stem Cells. ACS Applied Materials & Interfaces 15:1, pages 158-181.
Crossref
Rakshita Grover, Sahil Drall, Neelam Poonia, Gaurav Kumar Jain, Geeta Aggarwal, Viney Lather, Prashant Kesharwani, Deepti Pandita & Ramesh K. Goyal. (2023) CD44 and CD133 aptamer directed nanocarriers for cancer stem cells targeting. European Polymer Journal 183, pages 111770.
Crossref
Ezaldeen Esawi, Hamdi Nsairat, Ismail Sami Mahmoud, Zainab Lafi, Abdulfattah Al-Kadash, Bayan Abu Al-Ragheb, Said I. Ismail & Walhan Alhaer. 2023. Aptamers Engineered Nanocarriers for Cancer Therapy. Aptamers Engineered Nanocarriers for Cancer Therapy 481 520 .
Zongyi Wei, Yuxin Zhou, Rongjie Wang, Jin Wang & Zhenhua Chen. (2022) Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy. Pharmaceutics 14:12, pages 2561.
Crossref
Muneeb U. Rehman, Andleeb Khan, Zuha Imtiyaz, Shafat Ali, Hafiz Antar Makeen, Summya Rashid & Azher Arafah. (2022) Current nano-therapeutic approaches ameliorating inflammation in cancer progression. Seminars in Cancer Biology 86, pages 886-908.
Crossref
Karishma Shetty, Soma Yasaswi, Shilpee Dutt & Khushwant S. Yadav. (2022) Multifunctional nanocarriers for delivering siRNA and miRNA in glioblastoma therapy: advances in nanobiotechnology-based cancer therapy. 3 Biotech 12:11.
Crossref
Zixia Zhang, João Conniot, Joana Amorim, Yiliang Jin, Rajendra Prasad, Xiyun Yan, Kelong Fan & João Conde. (2022) Nucleic acid-based therapy for brain cancer: Challenges and strategies. Journal of Controlled Release 350, pages 80-92.
Crossref
Wenhao Liao, Yuchen Li, Jing Wang, Maoyuan Zhao, Nianzhi Chen, Qiao Zheng, Lina Wan, Yu Mou, Jianyuan Tang & Zhilei Wang. (2022) Natural Products-Based Nanoformulations: A New Approach Targeting CSCs to Cancer Therapy. International Journal of Nanomedicine Volume 17, pages 4163-4193.
Crossref
Yasamin Davatgaran Taghipour, Amir Zarebkohan, Roya Salehi, Fariborz Rahimi, Vladimir P. Torchilin, Michael R. Hamblin & Alexander Seifalian. (2022) An update on dual targeting strategy for cancer treatment. Journal of Controlled Release 349, pages 67-96.
Crossref
Hany E. Marei. (2022) Multimodal targeting of glioma with functionalized nanoparticles. Cancer Cell International 22:1.
Crossref
Bhavana Joshi & Abhijeet Joshi. (2021) Polymeric magnetic nanoparticles: a multitargeting approach for brain tumour therapy and imaging. Drug Delivery and Translational Research 12:7, pages 1588-1604.
Crossref
Meghanath B. Shete, Tulshidas S. Patil, Ashwini S. Deshpande, Gaurav Saraogi, Nupur Vasdev, Mrudul Deshpande, Kuldeep Rajpoot & Rakesh Kumar Tekade. (2022) Current trends in theranostic nanomedicines. Journal of Drug Delivery Science and Technology 71, pages 103280.
Crossref
Mahmood K. Mahabady, Sepideh Mirzaei, Hamidreza Saebfar, Mohammad H. Gholami, Amirhossein Zabolian, Kiavash Hushmandi, Farid Hashemi, Fatemeh Tajik, Mehrdad Hashemi, Alan P. Kumar, Amir R. Aref, Ali Zarrabi, Haroon Khan, Michael R. Hamblin, Yavuz Nuri Ertas & Saeed Samarghandian. (2022) Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity. Journal of Cellular Physiology 237:5, pages 2309-2344.
Crossref
Yung-Chih Kuo & Rajendiran Rajesh. (2022) Functionalized drug-gene delivery materials to transport inhibitor of apoptosis protein antagonists for tumor malignancy management. Journal of the Taiwan Institute of Chemical Engineers 133, pages 104283.
Crossref
Zihao Liu, Xiaoshuai Ji, Dong He, Rui Zhang, Qian Liu & Tao Xin. (2022) Nanoscale Drug Delivery Systems in Glioblastoma. Nanoscale Research Letters 17:1.
Crossref
Saffiya Habib & Moganavelli Singh. (2022) Angiopep-2-Modified Nanoparticles for Brain-Directed Delivery of Therapeutics: A Review. Polymers 14:4, pages 712.
Crossref
Buddolla Anantha Lakshmi & Young-Joon Kim. (2022) Modernistic and Emerging Developments of Nanotechnology in Glioblastoma-Targeted Theranostic Applications. International Journal of Molecular Sciences 23:3, pages 1641.
Crossref
Aviral Kumar, Amarnath Singam, Guruprasadh Swaminathan, Naresh Killi, Naveen Kumar Tangudu, Jedy Jose, Rathna Gundloori VN & Lekha Dinesh Kumar. (2022) Combinatorial therapy using RNAi and curcumin nano-architectures regresses tumors in breast and colon cancer models. Nanoscale 14:2, pages 492-505.
Crossref
Negar Bidar, Majid Darroudi, Ailin Ebrahimzadeh, Mohammadreza Safdari, Miguel de la Guardia, Behzad Baradaran, Vahabodin Goodarzi, Fatemeh Oroojalian & Ahad Mokhtarzadeh. (2022) Simultaneous nanocarrier-mediated delivery of siRNAs and chemotherapeutic agents in cancer therapy and diagnosis: Recent advances. European Journal of Pharmacology 915, pages 174639.
Crossref
Lei Wu, Wenhui Zhou, Lihua Lin, Anhong Chen, Jing Feng, Xiangmeng Qu, Hongbo Zhang & Jun Yue. (2022) Delivery of therapeutic oligonucleotides in nanoscale. Bioactive Materials 7, pages 292-323.
Crossref
Guoxiang Liu, Lina Yang, Guang Chen, Fenghua Xu, Fanghao Yang, Huaxin Yu, Lingne Li, Xiaolei Dong, Jingjing Han, Can Cao, Jingyu Qi, Junzhe Su, Xiaohui Xu, Xiaoxia Li & Bing Li. (2021) A Review on Drug Delivery System for Tumor Therapy. Frontiers in Pharmacology 12.
Crossref
Yavuz Nuri Ertas, Keyvan Abedi Dorcheh, Ali Akbari & Esmaiel Jabbari. (2021) Nanoparticles for Targeted Drug Delivery to Cancer Stem Cells: A Review of Recent Advances. Nanomaterials 11:7, pages 1755.
Crossref
Shangui Liu, Abdur Rauf Khan, Xiaoye Yang, Bo Dong, Jianbo Ji & Guangxi Zhai. (2021) The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy. Journal of Controlled Release 335, pages 1-20.
Crossref
Marcela Tavares Luiz, Leonardo Delello Di Filippo, Larissa Bueno Tofani, Jennifer Thayanne Cavalcante de Araújo, Jessyca Aparecida Paes Dutra, Juliana Maldonado Marchetti & Marlus Chorilli. (2021) Highlights in targeted nanoparticles as a delivery strategy for glioma treatment. International Journal of Pharmaceutics 604, pages 120758.
Crossref
Nour AlSawaftah, William G. Pitt & Ghaleb A. Husseini. (2021) Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment. ACS Pharmacology & Translational Science 4:3, pages 1028-1049.
Crossref
Zhuohong Li, Juncai Tian, Lei Du, Ying Gao, Yao Wang, Fengming You & Li Wang. (2021) Anlotinib exerts anti‐cancer efficiency on lung cancer stem cells in vitro and in vivo through reducing NF‐κB activity. Journal of Cellular and Molecular Medicine 25:12, pages 5547-5559.
Crossref
Solmaz Mojarad-Jabali, Masoud Farshbaf, Paul R. Walker, Salar Hemmati, Yousef Fatahi, Parvin Zakeri-Milani, Muhammad Sarfraz & Hadi Valizadeh. (2021) An update on actively targeted liposomes in advanced drug delivery to glioma. International Journal of Pharmaceutics 602, pages 120645.
Crossref
Lisha Chang, Yunhe Zhang, Min Li, Xiaojing Zhao, Dali Wang, Jian Liu, Fuling Zhou & Jiang Zhang. (2021) Nanostructured lipid carrier co-delivering paclitaxel and doxorubicin restrains the proliferation and promotes apoptosis of glioma stem cells via regulating PI3K/Akt/mTOR signaling. Nanotechnology 32:22, pages 225101.
Crossref
Yuan Ma, Sifan Yu, Shuaijian Ni, Baoxian Zhang, Angela Chun Fai Kung, Jin Gao, Aiping Lu & Ge Zhang. (2021) Targeting Strategies for Enhancing Paclitaxel Specificity in Chemotherapy. Frontiers in Cell and Developmental Biology 9.
Crossref
Louisa Taylor, Ian D. Kerr & Beth Coyle. (2021) Y-Box Binding Protein-1: A Neglected Target in Pediatric Brain Tumors?. Molecular Cancer Research 19:3, pages 375-387.
Crossref
Li Lihuang, Guo Qiuyan, Liu Yanxiu, Lu Mindan, Yang Jun, Ge Yunlong, Zhang Qiang, Sun Benqiang, Wang Xiumin, Li Liang-cheng & Ren Lei. (2021) Targeted combination therapy for glioblastoma by co-delivery of doxorubicin, YAP-siRNA and gold nanorods. Journal of Materials Science & Technology 63, pages 81-90.
Crossref
Priyanka Prabhu. 2021. Handbook on Nanobiomaterials for Therapeutics and Diagnostic Applications. Handbook on Nanobiomaterials for Therapeutics and Diagnostic Applications 53 101 .
Elia Bozzato, Chiara Bastiancich & Véronique Préat. (2020) Nanomedicine: A Useful Tool against Glioma Stem Cells. Cancers 13:1, pages 9.
Crossref
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, Farid Hashemi, Ebrahim Rahmani Moghadam, Mehdi Raei, Mahshad Kalantari, Shima Tavakol, Reza Mohammadinejad, Masoud Najafi, Franklin R. Tay & Pooyan Makvandi. (2020) Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy. ACS Combinatorial Science 22:12, pages 669-700.
Crossref
Paola Amero, Soumen Khatua, Cristian Rodriguez-Aguayo & Gabriel Lopez-Berestein. (2020) Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology. Cancers 12:10, pages 2889.
Crossref
Neerada Meenakshi Warrier, Prasoon Agarwal & Praveen Kumar. (2020) Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics. Stem Cell Reviews and Reports 16:5, pages 828-852.
Crossref
Jie Li, Tiantian Tan, Liping Zhao, Mengmeng Liu, Yu You, Yiying Zeng, Dajing Chen, Tian Xie, Lele Zhang, Chaomei Fu & Zhaowu Zeng. (2020) Recent Advancements in Liposome-Targeting Strategies for the Treatment of Gliomas: A Systematic Review. ACS Applied Bio Materials 3:9, pages 5500-5528.
Crossref
Kuldeep Rajpoot. (2020) Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications. Current Cancer Drug Targets 20:4, pages 271-287.
Crossref
Ranjita Misra, Sangeetha Kandoi, Sudha Varadaraj, S. Vijayalakshmi, A. Nanda & Rama S. Verma. (2020) Nanotheranostics: A tactic for cancer stem cells prognosis and management. Journal of Drug Delivery Science and Technology 55, pages 101457.
Crossref
Bin Liu, Wen Cao, Guanglei Qiao, Shanying Yao, Shaojun Pan, Lirui Wang, Caixia Yue, Lijun Ma, Yanlei Liu & Daxiang Cui. (2019) Effects of gold nanoprism-assisted human PD-L1 siRNA on both gene down-regulation and photothermal therapy on lung cancer. Acta Biomaterialia 99, pages 307-319.
Crossref
Steven Zanganeh, Petrina Georgala, Claudia Corbo, Leila Arabi, Jim Q. Ho, Najme Javdani, Mohammad R. Sepand, Kiara Cruickshank, Luis F. Campesato, Chien‐Huan Weng, Saeed Hemayat, Chrysafis Andreou, Ricardo Alvim, Gregor Hutter, Marjan Rafat & Morteza Mahmoudi. (2019) Immunoengineering in glioblastoma imaging and therapy. WIREs Nanomedicine and Nanobiotechnology 11:6.
Crossref
Mengtian Zhang, Qin Wang, Ka-Wai Wan, Waqar Ahmed, David A. Phoenix, Zhirong Zhang, Mohamed A. Elrayess, Abdelbary Elhissi & Xun Sun. (2019) Liposome mediated-CYP1A1 gene silencing nanomedicine prepared using lipid film-coated proliposomes as a potential treatment strategy of lung cancer. International Journal of Pharmaceutics 566, pages 185-193.
Crossref
Shanshan Wang & Rongqin Huang. (2019) Non‐viral nucleic acid delivery to the central nervous system and brain tumors. The Journal of Gene Medicine 21:7.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.